iRhythm Technologies Inc.
IRTC | NASDAQ
$110.38
+$1.05 (+0.96%)
At close: Sep 21, 2026, 4:00 PM ET
$110.38
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Company Profile
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Key Executives
| Name | Position |
|---|---|
| Quentin S. Blackford | President, Chief Executive Officer & Director |
| Brian Lawrence | Executive Vice President & Chief Technology Officer |
| Daniel G. Wilson | Chief Financial Officer & Principal Financial Officer |
| Chad Patterson | Chief Commercial and Product Officer |
| Lisa Pecora | Senior Vice President of Finance & Investor Relations |
| Marc Rosenbaum | Senior Vice President of Finance & Chief Accounting Officer |
| Mervin Smith | Executive Vice President of Business Operations |
| Minang Turakhia | Chief Medical & Scientific Officer and Executive Vice President of Advanced Technologies |
| Patrick Michael Murphy | Chief Business & Legal Officer |
| Sean Clinton Freeman | Executive Vice President of Strategy & Corporate Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 4 | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
iRhythm Technologies Inc.
| Country | United States |
| IPO Date | Oct 19, 2016 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 2,400 |
| CEO | Quentin S. Blackford |
Contact Details
699 8th Street San Francisco,
California 94103 United States
Stock Details
| Ticker Symbol | IRTC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001388658 |
| CUSIP Number | 450056106 |
| ISIN Number | US4500561067 |
| SIC Code | 3841 |
Recent News
- 18 days ago / zacks.comShould Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
- 27 days ago / globenewswire.comiRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
- 1 month ago / seekingalpha.comiRhythm: The Algorithmic Margin Inflection Changes The Story
- 1 month ago / gurufocus.comDid iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- 1 month ago / zacks.comiRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform
- 1 month ago / zacks.comHere's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock
- 1 month ago / zacks.comiRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised
- 2 months ago / benzinga.comiRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
- 2 months ago / seekingalpha.comiRhythm Holdings, Inc. (IRTC) Q2 2026 Earnings Call Transcript
- 2 months ago / zacks.comiRhythm Holdings, Inc. (IRTC) Tops Q2 Earnings and Revenue Estimates
Add to Watchlist
Select watchlists to add or remove IRTC